wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38710182-C6DB6460-847B-4E12-8371-D780C5F3F80B
Q38710182-C6DB6460-847B-4E12-8371-D780C5F3F80B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38710182-C6DB6460-847B-4E12-8371-D780C5F3F80B
ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA.
P2860
Q38710182-C6DB6460-847B-4E12-8371-D780C5F3F80B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38710182-C6DB6460-847B-4E12-8371-D780C5F3F80B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e28491395af7d1eed62490747de4e7cf0294dda9
P2860
Phase II Study of Irinotecan and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer